aXichem: Brazil needs to heat up
Research update Q3 2025
|2025-12-01
- aXivite order from Spain
- Application for fast-track registration in Brazil
- We keep our fair value of SEK 4,26 per share
For Q3 2025, aXichem reported sales of SEK 4.6 million, which was somewhat below our high expectations. The company’s CEO, Torsten Helsing, emphasized during the webcast that the continued focus is on increasing invoicing. Costs for the quarter came in below our estimates, mainly driven by lower personnel expenses. During the quarter, the first call-off order of aXiphen was delivered to Chr. Olesen in Brazil, with a value of approximately SEK 1.6 million. We need to see additional call-offs in the near term in order to justify our revenue forecast.
Read our research update. The research update is available in Swedish